Navigation Links
Doyle, WARF announce partnership to lure stem cell companies

Milwaukee, Wis. - In a move designed to give Wisconsin a competitive advantage over other states, Gov. Jim Doyle has announced a partnership agreement with the Wisconsin Alumni Research Foundation guaranteeing all companies that conduct stem cell research at non-profit and academic institutions in Wisconsin a free, non-exclusive research license under the ......

Full article >>> >Wisconsin Entrepreneur's Network to support companies that start or locate in Wisconsin.

State assistance to companies with accessing the Wisconsin Angel Network and with identifying incubators with wet lab space.

Doyle believes the agreement will pave the way for thousands of stem cell research jobs in Wisconsin, which he......

Full article >>> in state funding for WiCell to promote methods of stem cell extraction that don't involve the destruction of embryos. The proposal came after a barrage of criticism from Doyle because Green has opposed measures to expand federal funding for human embryonic stem cell research beyond cell lines that already existed when President Bush announced his ban on new ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 09/28/06


Related biology technology :

1. Doyle, Kind call for higher renewable fuel standard
2. Doyle, Green exchange stem cell salvos
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... 21, 2017 , ... Nova Oculus Partners has forged another ... device for the treatment of Age-Related Macular Degeneration. , The company’s chief operating ... consultancy that helps companies like ours secure government approvals for their medical devices. ...
(Date:1/21/2017)... -- Bioptix, Inc. (Nasdaq: BIOP ... 14, 2017 the Board of Directors of the Company ... certain employees associated with the September 2016 acquisition of ... on January 16, 2017 and terminations are expected to ... severance benefits in certain circumstances of up to one ...
(Date:1/21/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, today presented data from two clinical studies ... American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium ... In a Phase Ib/II study of napabucasin – ... stemness pathways by targeting STAT3 – colorectal cancer (CRC) ...
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
Breaking Biology Technology:
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer ... it has signed agreements with seven strategic partners across ... Middle East for commercialization of the Trovera™ ... of international distribution agreements for Trovagene,s CLIA based liquid ... The initial partners will introduce Trovagene,s liquid biopsy tests ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):